In:
Blood, American Society of Hematology, Vol. 127, No. 15 ( 2016-04-14), p. 1886-1895
Abstract:
A preclinical model system was developed to define the molecular landscape dictating lymphoma resistance to immunotherapy. This system revealed that Gal-1 significantly inhibits CD20 immunotherapy within the lymphoma microenvironment in vivo.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2015-11-681130
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2016
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7